120 related articles for article (PubMed ID: 11134158)
1. Regulation of aromatase expression in human ovarian surface epithelial cells.
Okubo T; Mok SC; Chen S
J Clin Endocrinol Metab; 2000 Dec; 85(12):4889-99. PubMed ID: 11134158
[TBL] [Abstract][Full Text] [Related]
2. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene.
Shozu M; Zhao Y; Simpson ER
Endocrinology; 1997 Dec; 138(12):5125-35. PubMed ID: 9389492
[TBL] [Abstract][Full Text] [Related]
3. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.
Shozu M; Zhao Y; Bulun SE; Simpson ER
Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211
[TBL] [Abstract][Full Text] [Related]
5. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads.
Bulun SE; Rosenthal IM; Brodie AM; Inkster SE; Zeller WP; DiGeorge AM; Frasier SD; Kilgore MW; Simpson ER
J Clin Endocrinol Metab; 1994 Feb; 78(2):1616-21. PubMed ID: 8106605
[TBL] [Abstract][Full Text] [Related]
6. Aromatase expression in ovarian epithelial cancers.
Cunat S; Rabenoelina F; Daurès JP; Katsaros D; Sasano H; Miller WR; Maudelonde T; Pujol P
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):15-24. PubMed ID: 15748828
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes.
Zhao Y; Mendelson CR; Simpson ER
Mol Endocrinol; 1995 Mar; 9(3):340-9. PubMed ID: 7776980
[TBL] [Abstract][Full Text] [Related]
8. Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction.
Zhou C; Zhou D; Esteban J; Murai J; Siiteri PK; Wilczynski S; Chen S
J Steroid Biochem Mol Biol; 1996 Oct; 59(2):163-71. PubMed ID: 9010331
[TBL] [Abstract][Full Text] [Related]
9. Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II.
Imir AG; Lin Z; Yin P; Deb S; Yilmaz B; Cetin M; Cetin A; Bulun SE
J Clin Endocrinol Metab; 2007 May; 92(5):1979-82. PubMed ID: 17341559
[TBL] [Abstract][Full Text] [Related]
10. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of aromatase in breast cancer tissues.
Harada N
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the regulatory regions of the human aromatase (P450arom) gene involved in placenta-specific expression.
Kamat A; Alcorn JL; Kunczt C; Mendelson CR
Mol Endocrinol; 1998 Nov; 12(11):1764-77. PubMed ID: 9817601
[TBL] [Abstract][Full Text] [Related]
13. Unique regulation of expression of human aromatase in the placenta.
Harada N; Yoshimura N; Honda S
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):327-34. PubMed ID: 14623529
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of promoter 1.3 activity of the human aromatase gene in breast tissue by zinc-finger protein, snail (SnaH).
Okubo T; Truong TK; Yu B; Itoh T; Zhao J; Grube B; Zhou D; Chen S
Cancer Res; 2001 Feb; 61(4):1338-46. PubMed ID: 11245431
[TBL] [Abstract][Full Text] [Related]
15. Different promoter usage for CYP19 gene expression in buffalo ovary and placenta.
Sharma D; Ghai S; Singh D
Gen Comp Endocrinol; 2009 Jul; 162(3):319-28. PubMed ID: 19375426
[TBL] [Abstract][Full Text] [Related]
16. Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissues.
Yang HJ; Shozu M; Murakami K; Sumitani H; Segawa T; Kasai T; Inoue M
J Clin Endocrinol Metab; 2002 Aug; 87(8):3745-53. PubMed ID: 12161505
[TBL] [Abstract][Full Text] [Related]
17. Methylseleninic acid is a novel suppressor of aromatase expression.
Gao R; Zhao L; Liu X; Rowan BG; Wabitsch M; Edwards DP; Nishi Y; Yanase T; Yu Q; Dong Y
J Endocrinol; 2012 Feb; 212(2):199-205. PubMed ID: 22128327
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
19. Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture.
Bulun SE; Simpson ER; Word RA
J Clin Endocrinol Metab; 1994 Mar; 78(3):736-43. PubMed ID: 8126151
[TBL] [Abstract][Full Text] [Related]
20. Proliferating human granulosa-lutein cells in long term monolayer culture: expression of aromatase, cholesterol side-chain cleavage, and 3 beta-hydroxysteroid dehydrogenase.
McAllister JM; Mason JI; Byrd W; Trant JM; Waterman MR; Simpson ER
J Clin Endocrinol Metab; 1990 Jul; 71(1):26-33. PubMed ID: 2370296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
